Unlock instant, AI-driven research and patent intelligence for your innovation.

Solanesol-modified paclitaxel prodrug and preparation method and application thereof

A technology for solanesol and paclitaxel, which is applied in the field of solanesol-modified paclitaxel prodrug and its preparation field, achieves the effects of simple and easy preparation method, improved stability and simple and easy synthesis method

Active Publication Date: 2021-11-26
HENAN UNIVERSITY
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, if both drug and carrier are cytotoxic in tumor tissue, then this problem can be solved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Solanesol-modified paclitaxel prodrug and preparation method and application thereof
  • Solanesol-modified paclitaxel prodrug and preparation method and application thereof
  • Solanesol-modified paclitaxel prodrug and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1: Synthesis of Ester-Linked Solanesol-Paclitaxel Prodrug (SOL-PTX)

[0042](1) Weigh 0.96g (9.59mmol) of succinic anhydride in 15mL of DMF, add 1mL of triethylamine, N 2 Under protection, solanesol (4.0g, 6.34mmol) and DMAP (0.39g, 3.19mmol) were dissolved in 20mL of anhydrous dichloromethane, and then the solution was dropped into into the above DMF solution, and stirred at room temperature for 48 h. After the reaction, the reaction solution was transferred to a separatory funnel, extracted twice with 30 mL of distilled water, and the solvent was removed by rotary evaporation. Petroleum ether: ethyl acetate = 1:1 (v:v) was used as the mobile phase to pass through the silica gel column, and the outflow of the product was monitored by TLC. The mobile phase was spin-dried and vacuum-dried to obtain the intermediate product MSS.

[0043] (2) Weigh MSS (0.63g, 0.88mmol), DCC (121mg, 0.59mmol), DMAP (108mg, 0.88mmol) and dissolve in 10mL dichloromethane, N 2 Pacli...

Embodiment 2

[0047] Example 2: Synthesis of Disulfide-Linked Solanesol-Paclitaxel Prodrug (SOL-SS-PTX)

[0048] (1) Weigh 1.31g (6.23mmol) of 3,3-dithiodipropionic acid, 1.28g (6.2mmol) of DCC and 0.2g (1.64mmol) of DMAP in 10mL of DMF, N 2 Under protection, dissolve solanesol (2.0g, 3.17mmoL) in 20mL of anhydrous dichloromethane, then drop the solution into the above solution at a rate of 2mL / min with a constant pressure dropping funnel, and stir at room temperature for 48h After the reaction, the reaction solution was transferred to a separatory funnel, extracted twice with 30 mL of distilled water, and the solvent was removed by rotary evaporation. Use petroleum ether: ethyl acetate = 1:1 (v:v) as the mobile phase to pass through the silica gel column, monitor the outflow of the product by TLC, spin the mobile phase to dryness, and dry it in vacuum to obtain the intermediate product MDPA.

[0049] (2) Weigh MDPA (0.72g, 0.88mmoL), DCC (121mg, 0.59mmoL), DMAP (108mg, 0.88mmoL) and disso...

Embodiment 3

[0053] Example 3: Preparation of solanesol-paclitaxel self-assembled prodrug nanoparticles

[0054] Precisely weigh 15 mg of the prodrug, dissolve it with 2 mL of absolute ethanol, slowly add the ethanol solution dropwise to 10 mL of deionized water under magnetic stirring, and allow it to self-assemble at room temperature to form uniform nanoparticles (SOL-PTX nanoparticles, SOL-SS-PTX nanoparticles). After stirring at room temperature for 12 hours, put it in a dialysis bag with a molecular weight cut-off of 3500kDA, dialyze with deionized water for 2 days, replace the deionized water every 6 hours to remove the organic solvent, and filter through a 0.22µm aqueous membrane to obtain the milky blue prodrug nano particle solution. Adopt dynamic light scattering method to measure its particle size and particle size distribution, the result is as follows image 3 shown. Depend on image 3 It can be seen that the particle size of the nanoparticles is about 100nm, the appearanc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a solanesol-modified paclitaxel prodrug and its preparation method and application. On this basis, a prodrug self-assembled nano drug delivery system is prepared. The particle size is uniform (about 100nm), and it can efficiently load paclitaxel. , the preparation method is simple and highly reproducible; the long-chain PEG modified on the surface of the nano-preparation by vitamin E polyethylene glycol succinate (TPGS) can effectively prolong the circulation of the drug in the body and improve the stability of the nano-preparation; in addition, with The disulfide bond-linked solanesol-paclitaxel prodrug can specifically release the drug in a reducing environment, and it is expected to realize the targeted accumulation of paclitaxel in the tumor site, improve the anti-tumor effect, and reduce the toxic and side effects on normal tissues; solanesol As a natural active drug, it has the functions of inhibiting tumor cells and increasing the sensitivity of cancer cells to anticancer drugs, and is expected to enhance the anticancer effect of paclitaxel.

Description

technical field [0001] The invention belongs to the technical field of medicinal chemistry, and in particular relates to a solanesol-modified paclitaxel prodrug and a preparation method and application thereof. Background technique [0002] Paclitaxel is a first-line drug widely used in the treatment of various cancers, mainly including breast cancer, ovarian cancer and non-small cell lung cancer, etc. It has a good anti-tumor effect. Cell mitosis to exert cytotoxicity has been widely used clinically, but its clinical therapeutic effect is limited due to its poor solubility in water, poor oral availability, and multidrug resistance. [0003] At present, most paclitaxel injections used clinically are paclitaxel solubilized in polyoxyethylene castor oil and ethanol (1:1), but polyoxyethylene castor oil may cause severe allergic reactions, which directly lead to If this preparation is used, serious toxic and side effects will occur. Therefore, improving the water solubility of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D305/14A61K47/69A61K47/55A61K31/337A61P35/00
CPCA61K31/337A61K47/55A61K47/6929A61P35/00C07B2200/07C07D305/14
Inventor 刘蕾王春云宋仕永张亚楠盛倩丽王天顺张梦颖王瑞
Owner HENAN UNIVERSITY